Delisting risk
Cocrystal Pharma (COCP)
Develops structure-designed antivirals for influenza, norovirus, and coronavirus infections.
$1.16
At close+0.04 (+3.57%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
estimated · in 71 days
EPS estimate
−$0.15
Revenue estimate
$105.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25May '26May '26Aug '26Nov '26
Reported−$0.32−$0.23−$0.20−$0.19−$0.17−$0.16−$0.23Pending
Estimate−$0.55−$0.52−$0.30−$0.22−$0.15−$0.15−$0.17−$0.15
Surprise+41.8%+55.8%+33.3%+13.6%−13.3%−6.7%−39.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25May '26May '26Aug '26Nov '26
Reported$136.0K———$225.0K—$105.0KPending
Estimate————$225.0K—$50.0K$105.0K
Surprise————0.0%—+110.0%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.15 | — | — |
| Aug 2026 | −$0.17 | −$0.23 | −39.4% |
| May 2026 | −$0.15 | −$0.16 | −6.7% |
| May 2026 | −$0.15 | −$0.17 | −13.3% |
| Nov 2025 | −$0.22 | −$0.19 | +13.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Apr 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.15 | — | — | $105.0K | — | — | — |
| Aug 13, 2026 | −$0.17 | −$0.23 | −39.4% | $50.0K | $105.0K | +110.0% | −1.8% |
| May 21, 2026 | −$0.15 | −$0.16 | −6.7% | — | — | — | +1.8% |
| May 15, 2026 | −$0.15 | −$0.17 | −13.3% | $225.0K | $225.0K | 0.0% | −1.7% |
| Nov 14, 2025 | −$0.22 | −$0.19 | +13.6% | — | — | — | −1.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 23, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 17, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 27, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 12, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 21, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 10, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Apr 29, 2016 | |||||||
| Nov 16, 2015 | |||||||
| Aug 14, 2015 | |||||||